Back to Search Start Over

Functional outcomes after primary versus delayed robot-assisted radical prostatectomy following active surveillance.

Authors :
Corsini C
Scilipoti P
Orrason AW
Gedeborg R
Westerberg M
Stattin P
Source :
JNCI cancer spectrum [JNCI Cancer Spectr] 2025 Feb 06. Date of Electronic Publication: 2025 Feb 06.
Publication Year :
2025
Publisher :
Ahead of Print

Abstract

Background: It is unknown if a period of active surveillance before prostatectomy for prostate cancer (PCa) worsens functional outcomes. The aim of this study was to compare functional outcomes after primary vs delayed robot-assisted radical prostatectomy.<br />Methods: We included men registered in the National Prostate Cancer Register of Sweden with low and favorable intermediate-risk PCa who underwent robot-assisted prostatectomy in 2018-2020 and had filled a questionnaire on patient-reported outcome measures. Multivariable logistic regression analysis was used to compare the functional outcomes of primary and delayed prostatectomy.<br />Results: 2571 men underwent primary, and 921 men underwent delayed prostatectomy. Delayed prostatectomy was not associated with reduced overall quality of life [adjusted Odds Ratio (OR) 1.04; 95% confidence interval (CI) 0.71-1.55] or erectile dysfunction (adjusted OR 0.90, 95% CI 0.69-1.22). Urinary incontinence was slightly more common after delayed prostatectomy (15% vs 11%; adjusted OR 1.38, 95% CI 0.91-2.01). There were weak associations between time to prostatectomy and urinary symptoms and bother, with a 3% annual increase in the risk for urinary incontinence (adjusted OR 1.03; 95% CI 0.94 - 1.13).<br />Conclusion: These results suggest that a period on active surveillance before robot-assisted radical prostatectomy has little detrimental effect on functional outcomes. Since only around half of men on active surveillance will transit to prostatectomy, these outcomes represent a worst-case scenario for men who start active surveillance. These results support the use of active surveillance for men with low-risk and favourable intermediate-risk PCa.<br /> (© The Author(s) 2025. Published by Oxford University Press.)

Details

Language :
English
ISSN :
2515-5091
Database :
MEDLINE
Journal :
JNCI cancer spectrum
Publication Type :
Academic Journal
Accession number :
39913357
Full Text :
https://doi.org/10.1093/jncics/pkaf020